Skip to main content Back to Top

Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Marylyn Ritchie

October 26, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Marylyn Ritchie and learning more about her session, AI and Direct-to-Consumer Genetic Testing: The Good, the Bad, and the Ugly. If you haven’t already, register for the Midyear clinical meeting today at


Marylyn RitchieDr. Marylyn D. Ritchie, PhD, (she/her) is a professor of genetics and director of the Institute for Biomedical Informatics at the University of Pennsylvania, Perelman School of Medicine. Dr. Ritchie has over 20 years of experience in translational bioinformatics and has authored over 400 publications. Dr. Ritchie was appointed as a Fellow of the American College of Medical Informatics in 2020 and elected as a member of the National Academy of Medicine in 2021.

Cynthia Von HeeringenCynthia von Heeringen is a scientific project director, educational programs at ASHP and is responsible for planning, coordinating, and executing medical education, continuing professional development programs, and other clinical resources for pharmacists and other healthcare professionals. This includes developing educational content for ASHP’s national meetings, industry supported activities, and certifications product line. With extensive experience in acute care clinical practice and operational supervision, she is passionate about medication safety and process optimization. She is a graduate of the University of Rhode Island College of Pharmacy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.